Neubase Therapeutics Inc. buy fchar99
Start price
14.07.17
/
50%
€248.59
Target price
01.12.17
€432.96
Performance (%)
74.17%
End price
01.12.17
€432.96
Summary
This prediction ended on 01.12.17 with a price of €432.96. The BUY prediction by fchar99 for Neubase Therapeutics Inc. saw massive gains of 74.17%. fchar99 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neubase Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% | 45.717% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% | 73.262% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% | 48.769% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% | 55.803% |
Comments by fchar99 for this prediction
In the thread NeuBase Therapeutics Inc. diskutieren
fchar99 stimmt dem Sentiment von 'Buy' zu
fchar99 stimmt am 14.07.2017 dem Buy-Gesamtsentiment mit dem Kursziel 4.2$ zu.
(Zielkurs erreicht)

